Identification of potent and broad-spectrum antibiotics from SAR studies of a synthetic vancomycin analogue

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 10, 2003, Pages 1683-1686

  Ahrendt, Kateri A ^a   Olsen, Jacob A ^a   Wakao, Masahiro ^a   Trias, Joaquim ^b   Ellman, Jonathan A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Versicor Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LEAD; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG POTENCY; ENTEROCOCCUS FAECIUM; PHENOTYPE;

ENTEROCOCCUS FAECIUM;

EID: 0038215381     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00243-9     Document Type: Article

References (21)

1. (a) Walsh C.T. Nature. 406:2000;775.
2. (b) Murray B.E.N. J. Engl. Med. 342:2000;710.
3. (c) Pearson H. Nature. 418:2002;469.
4. Barne C.J., Williams D.H. Annu. Rev. Microbiol. 38:1984;339.
5. (a) Walsh C.T., Fisher S.L., Park I.S., Prahalad M., Wu Z. Chem. Biol. 3:1996;21.
6. (b) Arthur M., Courvalin P. Antimicrob. Agents Chemother. 37:1993;1563.
7. Xu R., Greiveldinger G., Marenus L.E., Cooper A., Ellman J.A. J. Am. Chem. Soc. 121:1999;4898.
8. Harris C.M., Kannan R., Kopecka H., Harris T.M. J. Am. Chem. Soc. 107:1985;6652.
9. Kannan R., Harris C.M., Harris T.M., Waltho J.P., Skelton N.J., Williams D.H. J. Am. Chem. Soc. 110:1988;2946.
10. The synthesis of the macrocycle 2 is described in the Supporting Information of ref 4.
11. The following amino acid inputs were used: D- and L-isomers of Ala, Asn, Glu, His, Lys, N-Me-Phe, Phe, Pro, Thr, tetrahydroisoquinoline-3-carboxylic acid (Tic), Trp, Tyr, Val; the L-isomer of diaminopropionic acid (Dapa) and 1,2,3,4- tetrahydronorharman-3-carboxylic acid (Tpi); and racemic 1,3-dihydroisoindole carboxylic acid (Disc) and 1-aminocyclohexane-carboxylic acid (Achc).
12. Compounds were tested according to NCCLS protocols. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard, 5th ed.; NCCLS Document M7-A5; National Committee for Clinical Laboratory Standards: Wayne, PA, 2000.
13. (a) Sundram U.N., Griffin J.H., Nicas T.I. J. Am. Chem. Soc. 118:1996;13107.
14. (b) Stack, D. R., Thompson, R. C. World patent 9 738 706, 1997.
15. (c) Rao J., Yan L., Lahiri J., Whitesides G.M., Weis R.M., Warren H.S. Chem. Biol. 6:1999;353
16. (d) Nicolaou K.C., Hughes R., Cho S.Y., Winssinger N., Smethurst C., Labischinski H., Endermann R. Angew. Chem., Int. Ed. Eng. 39:2000;3823.
17. (a) Cooper M.A., Williams D.H. Chem. Biol. 6:1999;891.
18. (b) Ref 5c.
19. (c) Allen N.E., LeTourneau D.L., Hobbs J.N. Jr. Antimicrob. Agents Chemother. 41:1997;66.
20. Thompson L.A., Ellman J.A. Tetrahedron Lett. 35:1994;9333.
21. For a discussion of an alternative mode of action of monomeric vancomycin derivatives against resistant bacteria, see: Ge M., Chen Z., Onishi H.R., Kohler J., Silver L.L., Kerns R., Fukuzawa S., Thompson C., Kahne D. Science. 284:1999;507.